Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastoma

European Journal of Cancer

Volumn 43, Issue 16, 2007, Pages 2413-2422

  Koppen, Arjen ^a   Ait Aissa, Rachida ^a   Koster, Jan ^a   van Sluis, Peter G ^a   Øra, Ingrid ^a,c   Caron, Huib N ^a,b   Volckmann, Richard ^a   Versteeg, Rogier ^a   Valentijn, Linda J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

DNA replication; MCM; MYCN; Neuroblastoma

Indexed keywords

MINICHROMOSOME MAINTENANCE PROTEIN 10; MINICHROMOSOME MAINTENANCE PROTEIN 2; MINICHROMOSOME MAINTENANCE PROTEIN 7; MINICHROMOSOME MAINTENANCE PROTEIN 8; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NEUROBLASTOMA; NORTHERN BLOTTING; ONCOGENE C MYC; ONCOGENE MYCN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WESTERN BLOTTING;

CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENES, MYC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEUROBLASTOMA; NUCLEAR PROTEINS;

EID: 35448958146     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.07.024     Document Type: Article

References (65)

1. Blackwood E.M., and Eisenman R.N. Max; a helix-loop-helix zipper protein that forms a sequence-specific DNA binding complex with Myc. Science 251 (1991) 1211-1217
2. Prendergast G.C., Lawa D., and Ziff E.B. Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell 65 (1991) 395-407
3. Malynn B.A., de Alboran I.M., O'Hagan R.C., et al. N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev 14 11 (2000) 1390-1399
4. Johnston L.A., Prober D.A., Edgar B.A., Eisenman R.N., and Gallant P. Drosophila myc regulates cellular growth during development. Cell 98 6 (1999) 779-790
5. Schmidt E.V. The role of c-myc in regulation of translation initiation. Oncogene 23 18 (2004) 3217-3221
6. Boon K., Caron H.N., van Asperen R., et al. N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. Embo J 20 6 (2001) 1383-1393
7. Coller H.A., Grandori C., Tamayo P., et al. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci USA 97 7 (2000) 3260-3265
8. Goodman L.A., Liu B.C., Thiele C.J., et al. Modulation of N-myc expression alters the invasiveness of neuroblastoma. Clin Exp Metastasis 15 2 (1997) 130-139
9. Zhang X.Y., DeSalle L.M., Patel J.H., et al. Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proc Natl Acad Sci USA 102 39 (2005) 13968-13973
10. Valentijn L.J., Koppen A., van Asperen R., Root H.A., Haneveld F., and Versteeg R. Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes. Cancer Res 65 8 (2005) 3136-3145
11. Steiner P., Philipp A., Lukas J., et al. Identification of a Myc-dependent step during the formation of active G(1) cyclin-Cdk complexes. EMBO J 14 19 (1995) 4814-4826
12. Hermeking H., Rago C., Schuhmacher M., et al. Identification of CDK4 as a target of c-MYC. Proc Natl Acad Sci USA 97 5 (2000) 2229-2234
13. Bouchard C., Marquardt J., Bras A., Medema R.H., and Eilers M. Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. Embo J 23 14 (2004) 2830-2840
14. Jansendurr P., Meichle A., Steiner P., et al. Differential modulation of cyclin gene-expression by Myc. Proc Natl Acad Sci USA 90 8 (1993) 3685-3689
15. PerezRoger I., Solomon D.L.C., Sewing A., and Land H. Myc activation of cyclin E Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene 14 20 (1997) 2373-2381
16. Yin X.Y., Grove L., Datta N.S., Katula K., Long M.W., and Prochownik E.V. Inverse regulation of cyclin B1 by c-Myc and p53 and induction of tetraploidy by cyclin B1 overexpression. Cancer Res 61 17 (2001) 6487-6493
17. Schuhmacher M., Kohlhuber F., Holzel M., et al. The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res 29 2 (2001) 397-406
18. Staller P., Peukert K., Kiermaier A., et al. Repression of p15(INK4b) expression by Myc through association with Miz-1. Nat Cell Biol 3 4 (2001) 392-399
19. Seoane J., Le H.V., and Massague J. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419 6908 (2002) 729-734
20. Schwab M., Alitalo K., Klempnauer K.H., et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305 5931 (1983) 245-248
21. Rubie H., Hartmann O., Michon J., et al. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: Results of the French NBL 90 study. J Clin Oncol 15 3 (1997) 1171-1182
22. Lutz W., Stohr M., Schurmann J., Wenzel A., Lohr A., and Schwab M. Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells. Oncogene 13 4 (1996) 803-812
23. Bernards R., Dessain S.K., and Weinberg R.A. N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma. Cell 47 (1986) 667-674
24. Auffray C., and Rougeon F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumour RNA. Eur J Biochem 107 (1980) 303-314
25. Deprez R.H.L., Fijnvandraat A.C., Ruijter J.M., and Moorman A.F.M. Sensitivity and accuracy of quantitative real-time polymerase chain reaction using SYBR green I depends on cDNA synthesis conditions. Anal Biochem 307 1 (2002) 63-69
26. Vandesompele J., De Preter K., Pattyn F., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 7 (2002)
27. You J.S., and Bird R.C. Selective induction of cell-cycle regulatory genes Cdk1 (P34(Cdc2)), cyclins A/B, and the tumor-suppressor gene Rb in transformed-cells by okadaic acid. J Cell Physiol 164 2 (1995) 424-433
28. Takisawa H., Mimura S., and Kubota Y. Eukaryotic DNA replication: from pre-replication complex to initiation complex. Curr Opin Cell Biol 12 6 (2000) 690-696
29. Tye B.K. MCM proteins in DNA replication. Ann Rev Biochem 68 (1999) 649-686
30. Blow J.J., and Dutta A. Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol 6 6 (2005) 476-486
31. Shohet J.M., Hicks M.J., Plon S.E., et al. Minichromosom maintenance protein MCM7 is a direct target of MYCN transcription factor in neuroblastoma. Cancer Res 62 (2002) 1123-1128
32. Li Z.R., Van Calcar S., Qu C.X., Cavenee W.K., Zhang M.Q., and Ren B. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci USA 100 14 (2003) 8164-8169
33. Godfried M.B., Veenstra M., Von Sluis P., et al. The N-myc and c-mjc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Oncogene 21 13 (2002) 2097-2101
34. Coulson J.M., Edgson J.L., Marshal-Jones Z.V., Mulgrew R., Quinn J.P., and Woll P.J. Upstream stimulatory factor activates the vasopressin promoter via multiple motifs, including a non-canonical E-box. Biochem J 369 (2003) 549-561
35. Blackwell T.K., Huang J., Ma A., et al. Binding of Myc proteins to canonical and noncanonical DNA-sequences. Mol Cell Biol 13 9 (1993) 5216-5224
36. Blow J.J., and Dutta A. Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol 6 6 (2005) 476-486
37. Brodeur G.M., Pritchard J., Berthold F., et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11 8 (1993) 1466-1477
38. Boon K., Caron H.N., van Asperen R., et al. N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. Embo J 20 6 (2001) 1383-1393
39. Amati B., Alevizopuolos K., and Vlach J. Myc and the cell cycle. Front Biosci 3 (1998) 250-268
40. Staller P., Peukert K., Kiermaier A., et al. Repression of p15(INK4b) expression by Myc through association with Miz-1. Nat Cell Biol 3 4 (2001) 392-399
41. Seoane J., Le H.V., and Massague J. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419 6908 (2002) 729-734
42. Weinreich M., and Stillman B. Cdc7p-Dbf4p kinase binds to chromatin during S phase and is regulated by both the APC and the RAD53 checkpoint pathway. EMBO J 18 19 (1999) 5334-5346
43. Roberts B.T., Ying C.Y., Gautier J., and Maller J.L. DNA replication in vertebrates requires a homolog of the Cdc7 protein kinase. Proc Natl Acad Sci USA 96 6 (1999) 2800-2804
44. Gozuacik D.C.M., Lagorce D., et al. Identification and functional characterization of a new member of the human Mcm protein family: hMcm8. Nucleic Acids Res 31 2 (2003) 570-579
45. Maiorano D., Cuvier O., Danis E., and Mechali M. MCM8 is an MCM2-7-related protein that functions as a DNA helicase during replication elongation and not initiation. Cell 120 3 (2005) 315-328
46. Sawyer S.L., Cheng I.H., Chai W., and Tye B.K. Mcm10 and Cdc45 cooperate in origin activation in Saccharomyces cerevisiae. J Mol Biol 340 2 (2004) 195-202
47. Ricke R.M., and Bielinsky A.K. Mcm10 regulates the stability and chromatin association of DNA polymerase-a. Mol Cell 16 173 (2004) 185
48. Jares P., and Blow J.J. Xenopus cdc7 function is dependent on licensing but not on XORC, XCdc6, or CDK activity and is required for XCdc45 loading. Genes Dev 14 12 (2000) 1528-1540
49. Walter J., and Newport J. Initiation of eukaryotic DNA replication: origin unwinding and sequential chromatin association of Cdc45, RPA, and DNA polymerase alpha. Mol Cell 5 4 (2000) 617-627
50. Ying C.Y., and Gautier J. The ATPase activity of MCM2-7 is dispensable for pre-RC assembly but is required for DNA unwinding. EMBO J 24 24 (2005) 4334-4344
51. Fujita M., Yamada C., Tsurumi T., Hanaoka F., Matsuzawa K., and Inagaki M. Cell cycle- and chromatin binding state-dependent phosphorylation of human MCM heterohexameric complexes. A role for cdc2 kinase. J Biol Chem 273 27 (1998) 17095-17101
52. Hendrickson M., Madine M., Dalton S., and Gautier J. Phosphorylation of MCM4 by cdc2 protein kinase inhibits the activity of the minichromosome maintenance complex. Proc Natl Acad Sci USA 93 22 (1996) 12223-12228
53. Ishimi Y., Komamura-Kohno Y., You Z.Y., Omori A., and Kitagawa M. Inhibition of Mcm4,6,7 helicase activity by phosphorylation with cyclin A/Cdk2. J Biol Chem 275 21 (2000) 16235-16241
54. Wohlschlegel J.A., Dwyer B.T., Dhar S.K., Cvetic C., Walter J.C., and Dutta A. Inhibition of eukaryotic DNA replication by geminin binding to Cdt1. Science 290 5500 (2000) 2309-2312
55. Hyrien O., Marheineke K., and Goldar A. Paradoxes of eukaryotic DNA replication: MCM proteins and the random completion problem. Bioessays 25 2 (2003) 116-125
56. Cortez D., Glick G., and Elledge S.J. Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases. Proc Natl Acad Sci USA 101 27 (2004) 10078-10083
57. Ohtani K., Iwanaga R., Nakamura M., et al. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F. Oncogene 18 14 (1999) 2299-2309
58. Yoshida K., and Inoue I. Regulation of Geminin and Cdt1 expression by E2F transcription factors. Oncogene 23 21 (2004) 3802-3812
59. Schuldiner O., and Benvenisty N. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumours. Oncogene 20 36 (2001) 4984-4994
60. Sears R., Ohtani K., and Nevins J.R. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol Cell Biol 17 9 (1997) 5227-5235
61. Berwanger B., Hartmann O., Bergmann E., et al. Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma. Cancer Cell 2 5 (2002) 377-386
62. Hernando E., Nahle Z., Juan G., et al. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430 7001 (2004) 797-802
63. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., and Mendell J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435 7043 (2005) 839-843
64. Sears R., Ohtani K., and Nevins J.R. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol Cell Biol 17 9 (1997) 5227-5235
65. Molenaar J.J., van Sluis P., Boon K., Versteeg R., and Caron H.N. Rearrangements and increased expression of cyclin DI (CCNDI) in neuroblastoma. Genes Chromosomes Cancer 36 3 (2003) 242-249